Inspiration

INSPIRE MEDICAL SYSTEMS, INC. (NYSE: INSP) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Inspire Medical Systems, Inc.

Retrieved on: 
Tuesday, February 13, 2024
Court, Action Replay, OSA, Sleep apnea, News, Food, Advertising, Obstructive sleep apnea, Complaint, District court, Inspiration, Patient, Security (finance)

If you purchased or acquired Inspire Medical common stock, and/or would like to discuss your legal rights and options please visit Inspire Medical Systems, Inc.

Key Points: 
  • If you purchased or acquired Inspire Medical common stock, and/or would like to discuss your legal rights and options please visit Inspire Medical Systems, Inc.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
  • If you purchased or acquired Inspire Medical common stock, and/or would like to discuss your legal rights and options please visit Inspire Medical Systems, Inc.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

Paramount's Content for Change Delivers Impactful Initiatives in Las Vegas

Retrieved on: 
Tuesday, February 13, 2024
Bias, Mental health, Woman, EVP, Education, Marketing, Biophysical environment, The NFL Today, ESG, CFC, New England Patriots, Entrepreneurship, Paramount, Paramount Global, CBS Sports, Content, BIPOC, Inspiration, NFL, Root, Social impact, Athlete, Microsoft, CBS, Social justice, Partnership

Through its Content for Change (CFC) initiative, Paramount Global seeks to harness the power of content to combat bias and harmful stereotypes, transforming how the world sees people.

Key Points: 
  • Through its Content for Change (CFC) initiative, Paramount Global seeks to harness the power of content to combat bias and harmful stereotypes, transforming how the world sees people.
  • Murals for Change: Recognizing the power of art to spark meaningful conversations, Content for Change also unveiled its Murals For Change initiative.
  • "Through initiatives like Creators House, Murals for Change, and our powerful vignettes, we aim to redefine narratives, amplify underrepresented voices, and drive meaningful impact in Las Vegas and beyond."
  • For more information on the Content for Change program and initiatives, please visit Paramount's Content for Change website.

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Inspire Medical Systems, Inc. (INSP)

Retrieved on: 
Monday, February 12, 2024
GPM, Court, Suite, OSA, News, Inspiration, Defendant, Tobacco

You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.

Key Points: 
  • You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.
  • On this news, Inspire Medical’s stock price fell $31.79, or 19.8%, to close at $129.65 per share on November 8, 2023, thereby injuring investors.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • Glancy Prongay & Murray LLP, Los Angeles

AACSB Recognizes 26 Business Schools Leading Boldly

Retrieved on: 
Monday, February 12, 2024
Carbon, Sustainability, School, Grenoble School of Management, Entrepreneurship, AACSB, Education, Research, University, University of Alabama, Case Western Reserve University, Faculty, Inspiration, Knowledge, International business, Weatherhead School of Management

TAMPA, Fla., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Today, AACSB International (AACSB)—the world’s largest business education alliance—announces 26 business schools highlighted in its Innovations That Inspire member spotlight program.

Key Points: 
  • TAMPA, Fla., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Today, AACSB International (AACSB)—the world’s largest business education alliance—announces 26 business schools highlighted in its Innovations That Inspire member spotlight program.
  • This annual program recognizes institutions from around the world that serve as champions of change in business education.
  • In 2024, the highlights feature unique ways that business schools are leveraging innovation to drive new value for the communities they serve.
  • These schools are leading boldly to enable equitable access, empower problem-solvers, design timely curricula and credentials, deploy adaptive learning methods, create new knowledge, and develop societal impact leaders.

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Inspire Medical Systems, Inc. - INSP

Retrieved on: 
Sunday, February 11, 2024
Pomerantz, Court, Prior, News, Complaint, Ext, Inspiration, Patient, LLP, Action Replay, Pharmaceutical industry

NEW YORK, Feb. 11, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (“Inspire Medical” or the “Company”) (NYSE: INSP).

Key Points: 
  • NEW YORK, Feb. 11, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (“Inspire Medical” or the “Company”) (NYSE: INSP).
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • The class action concerns whether Inspire Medical and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

Global Tissue Engineering Research Analysis Report 2023: Market to Reach $8.9 Billion by 2028, Driven by Rising Funding and Investments and Advancements in Regenerative Medicines - ResearchAndMarkets.com

Retrieved on: 
Thursday, February 8, 2024
Manufacturing, Other Health, Stem Cells, Pharmaceutical, Medical Devices, Hospitals, Genetics, Cardiology, Science, Biotechnology, Other Science, Health, Engineering, Research, Medical Supplies, Government of India, Scaffolding, Investment, Growth, Accident, B cell, Collagen, Trauma, Orthopedic surgery, Regeneration, Biology, Tissue engineering, Inspiration, DST, 3D bioprinting, Market development, USD, Pharmaceutical industry

The global tissue engineering market is projected to reach USD 8.9 billion by 2028 from an estimated USD 4.4 billion in 2023, at a CAGR of 15.3%

Key Points: 
  • The global tissue engineering market is projected to reach USD 8.9 billion by 2028 from an estimated USD 4.4 billion in 2023, at a CAGR of 15.3%
    The growth of this market can be attributed to rising funding and investments for the development of advanced tissue engineering solutions and growing technological advancements in regenerative medicines.
  • The synthetic material segment accounted for the largest share of material in the global tissue engineering market in 2022.
  • The increasing advancements in cell therapies and regenerative medicines are promoting the growth of the tissue engineering market in the region.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the tissue engineering market.

Sleep Doctor partners with Airway Management to offer myTAP® Oral Appliance

Retrieved on: 
Wednesday, February 7, 2024
Partnership, Sleep, Policy, Patient, Airway management, Slumber (film), Inspiration, FDA, CPAP, Sleep apnea, Snoring, Health, UnitedHealth Group, Pharmaceutical industry

DALLAS, Feb. 7, 2024 /PRNewswire/ -- Airway Management, manufacturer of the most globally researched oral appliances, is excited to announce myTAP is now available through Sleep Doctor. This partnership is to help consumers suffering from snoring or sleep apnea or who may be CPAP non-compliant.

Key Points: 
  • DALLAS, Feb. 7, 2024 /PRNewswire/ -- Airway Management, manufacturer of the most globally researched oral appliances, is excited to announce myTAP is now available through Sleep Doctor .
  • Sleep Doctor is an online sleep wellness company dedicated to enabling millions of individuals each year to make well-informed choices on improving sleep.
  • By providing virtual consultations with doctors, at-home sleep testing, and top-notch treatment choices, Sleep Doctor is a comprehensive destination for consumers aiming to harness the power of quality sleep.
  • "We are thrilled to announce that Sleep Doctor is joining forces with Airway Management in a strategic partnership that will amplify our strengths in the sleep world," says the Sleep Doctor clinical team.

Inspired Announces Partnership with Kambi to Provide Virtual Sports Offering to the Kambi Sportsbook

Retrieved on: 
Wednesday, February 7, 2024
Partnership, Inspiration, Virtual sports, FN, Football, SVP, Virtual, Basketball

This integration will allow Kambi’s partners to leverage Inspired’s Virtual Sports line-up.

Key Points: 
  • This integration will allow Kambi’s partners to leverage Inspired’s Virtual Sports line-up.
  • Kambi undertook a rigorous competitive procurement process before ultimately selecting Inspired as its exclusive Virtuals Sports provider.
  • “We are thrilled to integrate Kambi’s first-class sports betting technology with our best-in-class Virtual Sports games,” said Brooks Pierce, Inspired President, and Chief Executive Officer.
  • Inspired has the largest and most diverse content portfolio currently available, including the most popular sport for every market.

INSPIRE MEDICAL SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Inspire Medical Systems, Inc. - INSP

Retrieved on: 
Wednesday, February 7, 2024
District court, Inspiration, Court, INSP, KSF

NEW ORLEANS, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 20, 2024 to file lead plaintiff applications in a securities class action lawsuit against Inspire Medical Systems, Inc. (NYSE: INSP), if they purchased the Company’s shares between May 3, 2023 and November 7, 2023, inclusive (the “Class Period”).

Key Points: 
  • NEW ORLEANS, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 20, 2024 to file lead plaintiff applications in a securities class action lawsuit against Inspire Medical Systems, Inc. (NYSE: INSP), if they purchased the Company’s shares between May 3, 2023 and November 7, 2023, inclusive (the “Class Period”).
  • This action is pending in the United States District Court for the District of Minnesota.
  • If you purchased shares of Inspire and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nyse-insp/ to learn more.
  • If you wish to serve as a lead plaintiff in this class action, you must petition the Court by February 20, 2024.

Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results and Reaffirms 2024 Outlook

Retrieved on: 
Tuesday, February 6, 2024
Investment, Obstructive sleep apnea, Growth, Patient, Webcast, Inspiration, Pharmaceutical industry

MINNEAPOLIS, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financial results for the quarter and year ended December 31, 2023.

Key Points: 
  • U.S. revenue for the quarter was $189.4 million, an increase of 41% as compared to the prior year quarter.
  • Fourth quarter revenue outside the U.S. was $3.1 million, a decrease of 16% as compared to the fourth quarter of 2022.
  • Gross margin was 85.4% for the three months ended December 31, 2023, compared to 83.9% for the corresponding prior year period.
  • Net income was $14.8 million for the fourth quarter of 2023, as compared to $3.2 million in the corresponding prior year period.